OR10B1P

Across TCGA pan-cancer cohorts, OR10B1P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated OR10B1P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OR10B1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR10B1P expression acts as an unfavorable survival marker, although some lineages such as UVM and HNSC show a favorable association.

LUAD, STAD, and ACC are the cancer types where OR10B1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	III,IV	0.253	0.662	<.001	111	view →
STAD	DFS	Tertile	All	0.257	0.446	<.001	84	view →
ACC	OS	Tertile	All	0.211	0.833	<.001	81	view →
COAD	OS	Tertile	IV	0.111	0.658	<.001	54	view →
UVM	OS	Tertile	All	1.000	0.513	.006	30	view →
HNSC	OS	Tertile	All	0.878	0.674	.021	30	view →
LGG	DFS	Tertile	All	0.531	0.753	.002	24	view →
BRCA	OS	Tertile	III,IV	0.717	0.914	.004	18	view →
DLBC	OS	Tertile	IV	0.147	0.850	.002	18	view →
TGCT	DFS	Tertile	All	0.323	0.678	.041	18	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	9	view →
LIHC	OS	Tertile	III,IV	0.213	0.648	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

OR10B1P–LUAD (DFS)

Open the LUAD breakdown →